Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:20 PM
Ignite Modification Date:
2025-12-26 @ 10:20 PM
NCT ID:
NCT01503112
Eligibility Criteria:
Inclusion Criteria:
* A clinical diagnosis of type 2 diabetes mellitus where the patient's clinician has determined the need for a DPP-IV inhibitor or GLP-1 analogue as a result of inadequate glycaemic control
* HbA1c \>= 58mmol/mol
Exclusion Criteria:
* Treatment with DPP-IV inhibitors or GLP-1 analogues prior to study initiation (within the previous 3 months)
* Renal failure as shown by a eGFR (estimated glomerular filtration rate) less than 30 mL/min/1.73m2
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01503112
Study Brief:
Protocol Section:
NCT01503112